One Lambda, Inc., the leader in antibody detection products, and the National Kidney Registry announced the introduction of The Toolbox, a new innovative web module. The Toolbox is designed to help medical professionals make intelligent decisions on donor selection based on antibody profiles of patients.
At the same time, The Toolbox will help medical professionals inform patients of the importance of recipient and donor preferences, and the impact that those preferences have on the probability of finding a match in the NKR’s pool.
The National Kidney Registry continues to improve upon its technology and expand its affiliations with top-tier transplant centers and organizations. The Toolbox is the most recent major technology enhancement implemented in the last six months. It follows an upgrade of its matching software, now capable of finding 20-deep chains and loops. The Toolbox capabilities will be showcased at the 2011 American Transplant Congress meeting in Philadelphia, April 30 to May 4 at the National Kidney Registry and One Lambda, Inc. booths.
“This innovative web tool is a true advancement for transplant patients waiting for a potential donor match,” said GS Jha, Director of IS for One Lambda, Inc. “Patient care is ultimately served when the best immunological match is made, and when the wait time for a procedure is shortened.”
“Over the past four years, I have personally seen many patients excluded from match offers due to inappropriate preference and antibody settings,” said Garet Hil, President and CEO of the National Kidney Registry. “The Toolbox will change this and allow our member centers to see the impact of these critical settings in real time and will facilitate many more transplants for our hard to match patients. We are fortunate to have teamed up with One Lambda. Their medical technology leadership will allow us to further reduce paired exchange wait times.”
About One Lambda, Inc.
One Lambda, Inc. (www.onelambda.com) is a world leader in the manufacture of HLA medical diagnostic products. Based in Canoga Park, California, the company is committed to developing products that improve the quality of life for transplant patients. Known for its dedication to quality, service and innovation since 1984, One Lambda, Inc. develops and distributes several lines of HLA typing and antibody detection products utilizing serological, molecular, ELISA, Flow and Luminex® xMAP® technologies. The company also manufactures laboratory instrumentation and software that simplify and automate testing procedures and final test evaluations. One Lambda’s products are sold worldwide.
Back to Press Releases